Miro JM - Search Results

1

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.

Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K; SPARTAC Trial Investigators. Hamlyn E, et al. Among authors: miro jm. AIDS. 2014 Mar 27;28(6):869-74. doi: 10.1097/QAD.0000000000000155. AIDS. 2014. PMID: 24300544 Clinical Trial.

2

Serum levels of beta2-microglobulin, neopterin, TNF-alpha and soluble receptors of TNF-alpha and interleukin-2 in intravenous drug abusers according to HIV-1 status and stage of the HIV-1 infection.

Bedini JL, García F, Miró JM, Aznar E, Serrano J, Lozano L, Mallolas J, Filella X, Vidal J, Latorre X, Gatell JM, Ballesta AM, Soriano E. Bedini JL, et al. Among authors: miro jm. Clin Microbiol Infect. 1998 Jan;4(1):4-10. doi: 10.1111/j.1469-0691.1998.tb00327.x. Clin Microbiol Infect. 1998. PMID: 11864226 Free article.

3

Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.

García F, Plana M, Mestre G, Arnedo M, Gil C, Miró JM, Cruceta A, Pumarola T, Gallart T, Gatell JM. García F, et al. Among authors: miro jm. AIDS. 2002 Sep 6;16(13):1761-5. doi: 10.1097/00002030-200209060-00008. AIDS. 2002. PMID: 12218387

4

Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.

Soriano A, Martínez C, García F, Plana M, Palou E, Lejeune M, Aróstegui JI, De Lazzari E, Rodriguez C, Barrasa A, Lorenzo JI, Alcamí J, del Romero J, Miró JM, Gatell JM, Gallart T. Soriano A, et al. Among authors: miro jm. J Infect Dis. 2002 Oct 1;186(7):922-31. doi: 10.1086/343741. Epub 2002 Sep 13. J Infect Dis. 2002. PMID: 12232832

5

[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].

Codina C, Martínez M, Tuset M, del Cacho E, Martín MT, Miró JM, Mallolas J, de Lazzari E, García F, Martínez E, Gatell JM, Ribas J. Codina C, et al. Among authors: miro jm. Enferm Infecc Microbiol Clin. 2002 Dec;20(10):484-90. doi: 10.1016/s0213-005x(02)72850-4. Enferm Infecc Microbiol Clin. 2002. PMID: 12433349 Spanish.

6

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.

García F, Plana M, Arnedo M, Ortiz GM, Miró JM, Lopalco L, Lori F, Pumarola T, Gallart T, Gatell JM. García F, et al. Among authors: miro jm. AIDS. 2003 Jan 3;17(1):43-51. doi: 10.1097/00002030-200301030-00007. AIDS. 2003. PMID: 12478068 Clinical Trial.

7

Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis.

Garcia F, Plana M, Mestre G, Cruceta A, Martinez E, Miró JM, Mallolas J, Tuset M, Pumorola T, Gallart T, Gatell JM. Garcia F, et al. Among authors: miro jm. Antivir Ther. 2002 Sep;7(3):195-7. Antivir Ther. 2002. PMID: 12487387 Clinical Trial.

8

Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.

Vidal C, Arnedo M, Garcia F, Mestre G, Plana M, Cruceta A, Capon A, Gallart T, Miro JM, Pumarola T, Gatell JM. Vidal C, et al. Among authors: miro jm. Antivir Ther. 2002 Dec;7(4):283-7. Antivir Ther. 2002. PMID: 12553483 Clinical Trial.

9

Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy.

Miró O, López S, Martínez E, Rodríguez-Santiago B, Blanco JL, Milinkovic A, Miró JM, Nunes V, Casademont J, Gatell JM, Cardellach F. Miró O, et al. Among authors: miro jm. AIDS Res Hum Retroviruses. 2003 Nov;19(11):1027-32. doi: 10.1089/088922203322588387. AIDS Res Hum Retroviruses. 2003. PMID: 14678610 Free article.

10

Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.

Navarrete P, Morente V, García F, Alós L, Arnedo M, Plana M, Gil C, Caballero M, Miró JM, Martínez E, Fumero E, Castro P, Blanco JL, Mallolas J, Blanch JL, Cruceta A, Mestre G, Pumarola T, Gallart T, Gatell JM. Navarrete P, et al. Among authors: miro jm. Antivir Ther. 2003 Dec;8(6):635-7. Antivir Ther. 2003. PMID: 14760898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

985 results

Search Page

Filters